301277 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Newland Pharmaceutical Co., Ltd. engages in the research, development, production, and sales of chiral pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Its main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid. The company was founded on September 15, 2005 and is headquartered in Changge, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
301277 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company